The federal government’s 340B Drug Pricing Program is designed to deliver significant drug price savings to eligible health care organizations and their patients. 

At noon on Wednesday, Jan. 29, subject matter experts from SunRx, a HASC Endorsed Business Partner, will present insights for safety net hospitals to tap into 340B program benefits. Information presented will empower hospital planners to more effectively target vulnerable populations, improve patient outcomes, and help underserved populations gain access to the discounted medications they need.

In today’s operating climate, safety net hospitals may struggle to stretch scarce resources to provide crucial services to patients while meeting their bottom line. When managed effectively, however, the 340B program can support the financial future of safety net organizations that serve the vulnerable populations. The program can have a significantly positive impact for hospitals, their patients, and their communities if hospitals know how to administer and manage the program.

Register today here to reserve your opportunity to learn from SunRx Director of Strategic Relations John Bretz and Regional Sales Manager Meredith Paige. 

With any questions, or for more information on the association’s Endorsed Business Partner program, please contact HASC Director, Member Relations and Association Services Darryl Sanford.

Contact:
Darryl Sanford
(213) 538-0772
dsanford@hasc.org